Pre-teens who struggle to control their video gaming habits are more likely to have psychotic-like experiences a year later, a new study has found.

McGill University researchers and colleagues at Maastricht University found that 12-year-olds who showed signs of problematic gaming were more likely to experience mild paranoia, unusual beliefs or disturbed perceptions at age 13.

Classified as: Vincent Paquin, Department of Psychiatry
Published on: 3 Mar 2026

Part of the largest CIHR-led cancer prevention investment, McGill researchers will develop approaches to reduce cancer risk and improve early detection 

Classified as: Canadian Institutes for Health Research (CIHR), CIHR, McGill University Health Centre (RI-MUHC), Lady Davis Institute (LDI), Department of Medicine, Gerald Bronfman Department of Oncology
Published on: 26 Feb 2026

Spending time in nature, even briefly, triggers changes in the brain that calm stress, restore attention and quiet mental clutter, a new study has found.

Researchers at McGill University and colleagues at Adolfo Ibáñez University in Chile have examined more than 100 brain-imaging studies from various disciplines. The result is one of the most comprehensive reviews to date of how the brain responds to nature.

Classified as: Mar Estarellas, Department of Psychiatry, nature
Published on: 26 Feb 2026

Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard treatment in a preclinical study.

Classified as: Guojun Chen, Department of Biomedical Engineering, Goodman Cancer Institute, cancer research
Published on: 18 Feb 2026

Scientists have identified a pattern of gene activity present in some female survivors of childhood abuse that is associated with an elevated risk of depression.

Classified as: Patricia Silveira, Department of Psychiatry, Douglas Mental Health University Institute
Published on: 13 Feb 2026

Friday February 13 2026 • 3pm to 5pm
McIntyre Building, room 330, 3655 Promenade Sir-William-Osler, Montreal QC, H3A 1A3

 

Published on: 4 Feb 2026

56 McGill research projects were awarded funding through CIHR’s Fall 2025 Project Grant competition, to support high-potential health research across all areas and career stages.  

Published on: 2 Feb 2026

The familiar labels “night owl” and “early bird,” long used in sleep research, don’t fully capture the diversity of human internal clocks, a new study has found.

The McGill University-led study published in Nature Communications found the two sleep-wake patterns, called chronotypes, contain a total of five distinct biological subtypes, each associated with different patterns of behaviour and health.

Classified as: Le Zhou, Danilo Bzdok, sleep, Department of Biomedical Engineering
Published on: 2 Feb 2026

For the first time, drug targeting genetic mutation shown to have positive impact in mice models

Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it even occurs.

Classified as: Carl Ernst, hydrocephalus, genetics, rare disease, Neuro
Published on: 29 Jan 2026

A preclinical study published in Nature has found evidence that the hippocampus, the brain region that stores memory, also reorganizes memories to anticipate future outcomes.

Classified as: Mark Brandon, Department of Psychiatry, Douglas Research Centre
Published on: 29 Jan 2026

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated with a reduced risk of dementia.

Drawing on clinical data from more than 450,000 patients, the research adds to growing evidence that incretin-based therapies have protective benefits for the brain.

The study examined GLP-1 receptor agonists, which include such medications as Ozempic, as well as DPP-4 inhibitors.

Classified as: Christel Renoux, Department of Neurology and Neurosurgery, Lady Davis Institute, GLP-1, dementia
Published on: 15 Jan 2026

Thursday March 12 2026 • 4:30pm to 6pm
Dentistry Suite #102, 2001 Avenue McGill College

Anna Papafragou, PhD
Professor • Department of Linguistics, University of Pennsylvania

Published on: 13 Jan 2026

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how scientists think about Parkinson’s disease treatments. 

Published in Nature Neuroscience, the research found dopamine does not set the speed or force of each movement, as had been thought. Instead, it appears to act as the underlying support system that makes movement possible. 

Classified as: Nicolas Tritsch, Department of Psychiatry, Douglas Research Centre, Parkinson’s
Published on: 17 Dec 2025

Pages

Back to top